ADVERTISEMENT
for patients with her genetic profile,” she told Maxwell. “It’s almost as if the treatment was created for someone exactly like Emily.”
Nexus Biotech.
The trial treatment came from Nexus Biotech.
A company William Harrington had championed aggressively.
A company continue reading …
ADVERTISEMENT